{"id":"NCT01137682","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly","officialTitle":"A Phase III, Multicenter, Randomized, Parallel-group Study to Assess the Efficacy and Safety of Double-blind Pasireotide LAR 40 mg and Pasireotide LAR 60 mg Versus Open-label Octreotide LAR or Lanreotide ATG in Patients With Inadequately Controlled Acromegaly","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-07-19","primaryCompletion":"2013-01-22","completion":"2017-02-28","firstPosted":"2010-06-04","resultsPosted":"2015-01-21","lastUpdate":"2018-04-05"},"enrollment":198,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acromegaly"],"interventions":[{"type":"DRUG","name":"Pasireotide","otherNames":["SOM230"]},{"type":"DRUG","name":"octreotide LAR 30mg","otherNames":[]},{"type":"DRUG","name":"lanreotide ATG 120mg","otherNames":[]}],"arms":[{"label":"Pasireotide LAR 40 mg","type":"EXPERIMENTAL"},{"label":"Pasireotide LAR 60 mg","type":"EXPERIMENTAL"},{"label":"Control arm (octreotide or lanreotide)","type":"ACTIVE_COMPARATOR"}],"summary":"This study will evaluate the efficacy and safety of pasireotide LAR 40 and 60 mg versus octreotide LAR or lanreotide ATG in patients with inadequately controlled acromegaly.","primaryOutcome":{"measure":"Percentage of Participants With a Reduction of Mean GH Levels to < 2.5 µg/L and Normalization of Sex- and Age-adjusted IGF-1.","timeFrame":"At 24 weeks","effectByArm":[{"arm":"Pasireotide LAR 40 mg","deltaMin":15.4,"sd":null},{"arm":"Pasireotide LAR 60 mg","deltaMin":20,"sd":null},{"arm":"Control Arm (Octreotide or Lanreotide)","deltaMin":0,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.0006"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":60,"countries":["United States","Argentina","Belgium","Brazil","Canada","Colombia","France","Germany","Israel","Italy","Norway","Poland","Romania","Russia","Saudi Arabia","Spain","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["32217809","25260838"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":63},"commonTop":["Hyperglycaemia","Diabetes mellitus","Cholelithiasis","Diarrhoea","Anaemia"]}}